Optimizing Patient Outcomes in CKD & T2D Care With CONFIDENCE
Rajiv Agarwal, MBBS, MD, FASN, BRCU
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
Riccardo Maria Inciardi, MD, PhD
Finerenone does not alter vascular stiffness in patients with T2D and CKD
Atsushi Tanaka, MD, PhD
Novel Therapies in Managing Patients With Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure
Cristina Gavina, MD, PhD
Giuseppe Galati, MD
Phase 3 study with oral semaglutide meets primary endpoint in high-risk T2D
Darren K. McGuire, MD
Expert opinion on the SOUL study results
Gina Lundberg, MD
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
Csaba P. Kovesdy, MD
Finnian R. McCausland, MD
ns-MRAs and eGFR Slope: The Kidney Perspective
Perspectives on CKM syndrome
Javed Butler, MD
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
Akshay S. Desai, MD
John McMurray, MD
Mastering MRA Monitoring: The Key to Success
Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy
Gianluigi Savarese, MD
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
James Burton, DM, FRCP
Aaron Wong, MD
Summarizing multidisciplinary strategies: Where do we go from here?
Definition and Staging of CKM Syndrome
Carolyn S. P. Lam, MBBS, PhD
Screening for CKM Syndrome
Jürgen Floege, MD
Loading...
We're glad to see you're enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.